PE or PEERLESS, the choice of therapy was shifting, influenced by patient factors and institutional protocols.

Please provide your email address to receive an email when new articles are posted on . Catheter-directed thrombolysis was linked to less major bleeding than mechanical thrombectomy in patients with ...

Please provide your email address to receive an email when new articles are posted on . A novel thrombectomy system beat safety and efficacy performance goals for treatment of patients with pulmonary ...

Early mechanical thrombectomy, within 12 hours of symptom onset, significantly improves patient hemodynamics in acute pulmonary embolism cases. The FLASH registry data support the safety and efficacy ...

BOSTON — The sooner that patients with acute pulmonary embolism (PE) get treated with mechanical thrombectomy, the greater the likelihood that they will have favorable short- and long-term outcomes, ...

Results of AVENTUS IDE Trial presented at SCAI Scientific Sessions MENLO PARK, Calif. and WASHINGTON, May 02, 2025 (GLOBE NEWSWIRE) -- Inquis Medical, a leading innovator in venous thromboembolic ...

The 2026 AHA/ACC guidelines introduce a five-tier Acute PE Clinical Category system to stratify severity and guide treatment decisions. Mechanical thrombectomy receives a Class 2a recommendation for ...

WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although ...

New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were ...

MENLO PARK, Calif., Feb. 20, 2024 /PRNewswire/ -- Endovascular Engineering, Inc. ("E2"), a pioneering medical device company at the forefront of advancing clot removal technologies for venous ...

Elizabeth Simms was 27 and pregnant when she was struck with a life-threatening pulmonary embolism. Her fourth pregnancy had been generally uncomplicated. Elizabeth was busy chasing her three young ...